NIH Teaming Up With Pharma Giants For New Treatments

The National Institute of Health announced Thursday that three pharmaceutical companies will be granting them access to industry compounds in an attempt to help the Institute spearhead new research into treatments for a wide variety of conditions.

“Americans are eagerly awaiting the next generation of cures and treatments to help them live longer and healthier lives,” Health and Human ServiceTo accelerate our nation’s therapeutic development process, it is essential that we forge strong, innovative, and strategic partnerships across government, academia and industry.”

The companies include AstraZeneca, Lilly and Pfizer and the NIH says that additional companies may eventually sign on. The compounds will be supplied to the NIH’s newly formed Natonal Center for Advancing Translational Sciences.

Tags: , , ,

About TRNS Washington Desk

View all posts by TRNS Washington Desk
TRNS Washington Desk
News updates from on and around Capitol Hill.

Emergency WHO Meeting: Ebola Remains International Health Emergency

It was the third meeting of the World Health Organization’s Emergency Committee on Ebola.

Health Care Initiative Launches Ahead Of Open Enrollment

The press release said that the initiative is “one part of a strategy advanced by the Affordable Care Act,” also known as Obamacare.

Latest White House Jumper Charged With Felonies

The Maryland man was charged with four misdemeanors and three felony counts for attacking Secret Service dogs.

Lincoln Suspends Habeas Corpus, 241 Troops Die In Lebanon Suicide Bombing, And Nixon Releases His Audio Tapes

Plus, the Senate turns down Robert Bork and thousands of women march on New York City.

Interview: Mark Fish, Libertarian Candidate For Alaska

Alaska is a key race in the upcoming midterm elections.

Lawmakers Raise Questions Over Whisper’s Privacy Policy

The social media platform faces allegations that it shared data and tracked users.